Boston Scientific Corp (BSX)

Receivables turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue (ttm)	US$ in thousands	16,746,000	15,910,000	15,228,000	14,707,000	14,240,000	13,757,000	13,400,000	13,045,000	12,682,000	12,567,000	12,329,000	12,162,000	11,888,000	11,469,000	11,196,000	10,122,000	9,913,000	10,110,000	10,158,000	10,786,000
Receivables	US$ in thousands	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Receivables turnover		—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

December 31, 2024 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $16,746,000K ÷ $—K
= —

The provided data indicates that the receivables turnover ratio for Boston Scientific Corp is not available for the periods from March 31, 2020, to December 31, 2024. The absence of specific values for the receivables turnover ratio across this entire timeframe hinders the ability to assess the efficiency of the company in collecting its accounts receivables.

The receivables turnover ratio is a financial metric that helps assess how effectively a company is managing its credit sales and collecting outstanding receivables. A higher turnover ratio generally indicates that the company is efficient in converting its credit sales into cash. Conversely, a lower turnover ratio may suggest issues with collection practices or potential credit risks.

Given the absence of data for Boston Scientific Corp's receivables turnover ratio, it is challenging to evaluate the company's performance in managing its receivables efficiently over the specified periods. Further information or updated financial data would be needed to conduct a thorough analysis of the company's receivables management and its impact on overall financial performance.